MedaSync Secures Strategic Investment
MedaSync, a Cleveland, OH-based AI-powered reimbursement optimization platform for skilled nursing facilities, has secured a strategic investment.
MedaSync, a Cleveland, OH-based AI-powered reimbursement optimization platform for skilled nursing facilities, has secured a strategic investment.
Investors
The investment was led by Omega Healthcare Investors, Inc., a real estate investment trust specializing in the long-term healthcare sector, with a primary focus on skilled nursing and assisted living facilities. Its portfolio is operated by a diverse group of healthcare companies, predominantly under triple-net lease structures. The assets span regions across the U.S. as well as the U.K.
Megan Krull, Senior Vice President of Operations at Omega Healthcare Investors, Inc., will join the MedaSync Board of Directors.
MedaSync Use of Funds
The company will use the funding to expand its market presence, accelerate customer adoption, and scale the development of new SaaS products.
About MedaSync
Led by CEO Ryan Edgerly, MedaSync is a healthcare technology company specializing in AI-driven reimbursement software designed to improve revenue efficiency across all payers serving skilled nursing organizations. Its machine learning platform streamlines reimbursement by generating intelligent patient summaries that automatically flag misalignments and highlight potential quality incentive risks. These insights are tailored to each organization’s PDPM, CMI, QIP programs, and level-based plans. Headquartered in Cleveland, Ohio, MedaSync serves hundreds of skilled nursing organizations.
Funding Details
Company: MedaSync
Raised: Undisclosed
Round: Strategic Investment
Funding Date: August 2025
Lead Investor: Omega Healthcare Investors, Inc.
Additional Investors:
Company Website: https://www.medasync.com/
Software Category: AI / HealthTech / Reimbursement Optimization
